PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2141876
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2141876
Connected Drug Delivery Devices Market Insights, Competitive Landscape, and Market Forecast - 2033
Connected Drug Delivery Devices Market Projected to Reach US$24.32 Bn by 2033
Introduction
The global connected drug delivery devices market is valued at US$8.2 Bn in 2026 and projected to reach US$24.32 Bn by 2033, at a CAGR of 16.8% during 2026-2033. Fairfield Market Research assesses the market through its published product, customer and geographical classifications. The forecast provides a common basis for evaluating commercial priorities across the study period.
Market Insights
The product type breakdown covers Connected Insulin Pens & Pumps, Connected Inhalers, Connected Auto-Injectors and Others. The application breakdown covers Diabetes Management, Respiratory Disease Management and Others. The connectivity type breakdown covers Bluetooth-Enabled and Cellular-Connected. These distinctions help businesses assess which offerings and customer requirements fall within the market's scope. The global forecast should be read alongside these segment definitions rather than applied uniformly to every individual category.
Within the product type classification, Connected Insulin Pens & Pumps and Connected Inhalers represent separate categories in the report. Keeping these categories distinct helps readers evaluate the fit of an offering before applying the overall market forecast to a specific commercial plan.
Within the application classification, Diabetes Management and Respiratory Disease Management represent separate categories in the report. Keeping these categories distinct helps readers evaluate the fit of an offering before applying the overall market forecast to a specific commercial plan.
Within the connectivity type classification, Bluetooth-Enabled and Cellular-Connected represent separate categories in the report. Keeping these categories distinct helps readers evaluate the fit of an offering before applying the overall market forecast to a specific commercial plan.
Drivers
Fairfield's growth discussion addresses connected insulin pens & pumps, diabetes management and bluetooth-enabled. These themes provide a starting point for assessing demand conditions and the requirements facing suppliers. Their commercial importance depends on the segment, customer and region concerned. Businesses can use the report's detailed discussion to connect these demand factors with their own portfolios and sales priorities.
Business Opportunity
The opportunity discussion highlights product type, application and connectivity type. Companies evaluating expansion can compare these areas with their existing capabilities, route to market and customer needs. Segment selection and regional positioning remain central to assessing the relevance of the published forecast to an individual business.
Businesses considering Connected Insulin Pens & Pumps can compare its customer requirements with those associated with Connected Inhalers. This comparison can help define a more focused portfolio, identify the appropriate sales audience and establish which questions require additional segment evidence before resources are committed.
Businesses considering Diabetes Management can compare its customer requirements with those associated with Respiratory Disease Management. This comparison can help define a more focused portfolio, identify the appropriate sales audience and establish which questions require additional segment evidence before resources are committed.
Businesses considering Bluetooth-Enabled can compare its customer requirements with those associated with Cellular-Connected. This comparison can help define a more focused portfolio, identify the appropriate sales audience and establish which questions require additional segment evidence before resources are committed.
Region Analysis
North America is identified in Fairfield's regional analysis as a leading market. The geographical scope covers North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Regional comparisons should use the report's own market definitions and forecast period.
Key Players
- Becton, Dickinson and Company
- Novo Nordisk A/S
- Ypsomed Holding AG
- Medtronic plc
- Insulet Corporation
- Tandem Diabetes Care, Inc.
- Halozyme Therapeutics, Inc.
- Elcam Medical
- Molex, LLC
- SHL Medical AG
Segmentation
By Product Type
- Connected Insulin Pens & Pumps
- Connected Inhalers
- Connected Auto-Injectors
- Others
By Application
- Diabetes Management
- Respiratory Disease Management
- Others
By Connectivity Type
- Bluetooth-Enabled
- Cellular-Connected
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Connected Drug Delivery Devices Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Five Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Connected Drug Delivery Devices Market Outlook, 2020 - 2033
- 3.1. Global Connected Drug Delivery Devices Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 3.1.1. Connected Insulin Pens & Pumps
- 3.1.2. Connected Inhalers
- 3.1.3. Connected Auto-Injectors
- 3.1.4. Others
- 3.2. Global Connected Drug Delivery Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 3.2.1. Diabetes Management
- 3.2.2. Respiratory Disease Management
- 3.2.3. Others
- 3.3. Global Connected Drug Delivery Devices Market Outlook, by Connectivity Type, Value (US$ Bn), 2020-2033
- 3.3.1. Bluetooth-Enabled
- 3.3.2. Cellular-Connected
- 3.4. Global Connected Drug Delivery Devices Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.4.1. North America
- 3.4.2. Europe
- 3.4.3. Asia Pacific
- 3.4.4. Latin America
- 3.4.5. Middle East & Africa
4. North America Connected Drug Delivery Devices Market Outlook, 2020 - 2033
- 4.1. North America Connected Drug Delivery Devices Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 4.1.1. Connected Insulin Pens & Pumps
- 4.1.2. Connected Inhalers
- 4.1.3. Connected Auto-Injectors
- 4.1.4. Others
- 4.2. North America Connected Drug Delivery Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 4.2.1. Diabetes Management
- 4.2.2. Respiratory Disease Management
- 4.2.3. Others
- 4.3. North America Connected Drug Delivery Devices Market Outlook, by Connectivity Type, Value (US$ Bn), 2020-2033
- 4.3.1. Bluetooth-Enabled
- 4.3.2. Cellular-Connected
- 4.4. North America Connected Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.4.1. U.S. Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 4.4.2. U.S. Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 4.4.3. U.S. Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 4.4.4. Canada Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 4.4.5. Canada Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 4.4.6. Canada Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Connected Drug Delivery Devices Market Outlook, 2020 - 2033
- 5.1. Europe Connected Drug Delivery Devices Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 5.1.1. Connected Insulin Pens & Pumps
- 5.1.2. Connected Inhalers
- 5.1.3. Connected Auto-Injectors
- 5.1.4. Others
- 5.2. Europe Connected Drug Delivery Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 5.2.1. Diabetes Management
- 5.2.2. Respiratory Disease Management
- 5.2.3. Others
- 5.3. Europe Connected Drug Delivery Devices Market Outlook, by Connectivity Type, Value (US$ Bn), 2020-2033
- 5.3.1. Bluetooth-Enabled
- 5.3.2. Cellular-Connected
- 5.4. Europe Connected Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.4.1. Germany Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 5.4.2. Germany Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 5.4.3. Germany Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 5.4.4. Italy Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 5.4.5. Italy Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 5.4.6. Italy Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 5.4.7. France Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 5.4.8. France Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 5.4.9. France Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 5.4.10. U.K. Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 5.4.11. U.K. Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 5.4.12. U.K. Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 5.4.13. Spain Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 5.4.14. Spain Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 5.4.15. Spain Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 5.4.16. Russia Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 5.4.17. Russia Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 5.4.18. Russia Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 5.4.19. Rest of Europe Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 5.4.20. Rest of Europe Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 5.4.21. Rest of Europe Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Connected Drug Delivery Devices Market Outlook, 2020 - 2033
- 6.1. Asia Pacific Connected Drug Delivery Devices Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 6.1.1. Connected Insulin Pens & Pumps
- 6.1.2. Connected Inhalers
- 6.1.3. Connected Auto-Injectors
- 6.1.4. Others
- 6.2. Asia Pacific Connected Drug Delivery Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 6.2.1. Diabetes Management
- 6.2.2. Respiratory Disease Management
- 6.2.3. Others
- 6.3. Asia Pacific Connected Drug Delivery Devices Market Outlook, by Connectivity Type, Value (US$ Bn), 2020-2033
- 6.3.1. Bluetooth-Enabled
- 6.3.2. Cellular-Connected
- 6.4. Asia Pacific Connected Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.4.1. China Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 6.4.2. China Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 6.4.3. China Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 6.4.4. Japan Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 6.4.5. Japan Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 6.4.6. Japan Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 6.4.7. South Korea Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 6.4.8. South Korea Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 6.4.9. South Korea Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 6.4.10. India Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 6.4.11. India Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 6.4.12. India Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 6.4.13. Southeast Asia Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 6.4.14. Southeast Asia Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 6.4.15. Southeast Asia Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 6.4.16. Rest of SAO Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 6.4.17. Rest of SAO Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 6.4.18. Rest of SAO Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Connected Drug Delivery Devices Market Outlook, 2020 - 2033
- 7.1. Latin America Connected Drug Delivery Devices Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 7.1.1. Connected Insulin Pens & Pumps
- 7.1.2. Connected Inhalers
- 7.1.3. Connected Auto-Injectors
- 7.1.4. Others
- 7.2. Latin America Connected Drug Delivery Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 7.2.1. Diabetes Management
- 7.2.2. Respiratory Disease Management
- 7.2.3. Others
- 7.3. Latin America Connected Drug Delivery Devices Market Outlook, by Connectivity Type, Value (US$ Bn), 2020-2033
- 7.3.1. Bluetooth-Enabled
- 7.3.2. Cellular-Connected
- 7.4. Latin America Connected Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.4.1. Brazil Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 7.4.2. Brazil Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 7.4.3. Brazil Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 7.4.4. Mexico Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 7.4.5. Mexico Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 7.4.6. Mexico Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 7.4.7. Argentina Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 7.4.8. Argentina Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 7.4.9. Argentina Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 7.4.10. Rest of LATAM Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 7.4.11. Rest of LATAM Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 7.4.12. Rest of LATAM Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Connected Drug Delivery Devices Market Outlook, 2020 - 2033
- 8.1. Middle East & Africa Connected Drug Delivery Devices Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 8.1.1. Connected Insulin Pens & Pumps
- 8.1.2. Connected Inhalers
- 8.1.3. Connected Auto-Injectors
- 8.1.4. Others
- 8.2. Middle East & Africa Connected Drug Delivery Devices Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 8.2.1. Diabetes Management
- 8.2.2. Respiratory Disease Management
- 8.2.3. Others
- 8.3. Middle East & Africa Connected Drug Delivery Devices Market Outlook, by Connectivity Type, Value (US$ Bn), 2020-2033
- 8.3.1. Bluetooth-Enabled
- 8.3.2. Cellular-Connected
- 8.4. Middle East & Africa Connected Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.4.1. GCC Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 8.4.2. GCC Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 8.4.3. GCC Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 8.4.4. South Africa Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 8.4.5. South Africa Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 8.4.6. South Africa Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 8.4.7. Egypt Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 8.4.8. Egypt Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 8.4.9. Egypt Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 8.4.10. Nigeria Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 8.4.11. Nigeria Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 8.4.12. Nigeria Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 8.4.13. Rest of Middle East Connected Drug Delivery Devices Market Outlook, by Product Type, 2020-2033
- 8.4.14. Rest of Middle East Connected Drug Delivery Devices Market Outlook, by Application, 2020-2033
- 8.4.15. Rest of Middle East Connected Drug Delivery Devices Market Outlook, by Connectivity Type, 2020-2033
- 8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Becton, Dickinson and Company
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Novo Nordisk A/S
- 9.4.3. Ypsomed Holding AG
- 9.4.4. Medtronic plc
- 9.4.5. Insulet Corporation
- 9.4.6. Tandem Diabetes Care, Inc.
- 9.4.7. Halozyme Therapeutics, Inc.
- 9.4.8. Elcam Medical
- 9.4.9. Molex, LLC
- 9.4.10. SHL Medical AG
- 9.4.1. Becton, Dickinson and Company
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
